3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Vipoma
1
Tongue Neoplasms
1
Stomatitis
1
Radiation Injuries
1
Prostatic Neoplasms
1
Neuroendocrine Tumors
1
Head and Neck Neoplasms
1
Gliosarcoma
1
Glioblastoma
1
Esthesioneuroblastoma, Olfactory
1
Interventions
3-Iodobenzylguanidine
3
cabozantinib
2
pembrolizumab
1
pazopanib
1
lutetium Lu 177 dotatate
1
guadecitabine
1
gallium Ga 68 dotatate
1
copper dotatate CU-64
1
atezolizumab
1
Sunitinib
1
Radiosurgery
1
Phenoxybenzamine
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Lutetium-177
1
Lutetium
1
Iodine-131
1
Everolimus
1
Erlotinib Hydrochloride
1
Doxazosin
1
Axitinib
1
3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Paraganglioma
×
Salts
×
Clear all
No trials found.